just on the US market numbers, there are currently around 32 million people with diabetes. If we assume a standard royalty rate of 7.5% (industry standards range from 5-15%) and a 10% take up of the test per annum and a US$150 cost of the test, that equates to around AUD$52 million in royalties per annum. if you assume a 15% penetration rate, that equates to around AUD$78 million per annum. PIQ is undervalued on so many metrics in my opinion.
DYOR
PIQ Price at posting:
98.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)